Author/Creator: McGeeney, Danielle - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator McGeeney, Danielle

1. A Single Supratherapeutic Dose of Atogepant Does Not Affect Cardiac Repolarization in Healthy Adults: Results From a Randomized, Single‐Dose, Phase 1 Crossover Trial. Issue 9 (4th May 2021)

Authors:: Boinpally, Ramesh; McNamee, Brian; Yao, Li; Butler, Matthew; McGeeney, Danielle; Borbridge, Lisa; Periclou, Antonia
Journal:: Clinical pharmacology in drug development
Issue:: Volume 10:Issue 9(2021)
Page Start:: 1099
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. An Open‐Label Study to Evaluate the Effect of Eluxadoline on the Single‐Dose Pharmacokinetics of Midazolam in Healthy Participants. Issue 11 (8th August 2022)

Authors:: Boinpally, Ramesh; McGeeney, Danielle; Kaczynski, Edward; Weissman, Darren
Journal:: Clinical pharmacology in drug development
Issue:: Volume 11:Issue 11(2022)
Page Start:: 1341
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Evaluation of the pharmacokinetic interaction and safety of ubrogepant coadministered with acetaminophen or nonsteroidal anti-inflammatory drugs: A randomized trial. (1st May 2020)

Authors:: Jakate, Abhijeet; Boinpally, Ramesh; Butler, Matthew; Lu, Kaifeng; Womack, Kristi; McGeeney, Danielle; Periclou, Antonia
Journal:: Cephalalgia reports
Issue:: Volume 3(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Evaluation of the Pharmacokinetic Interaction of Ubrogepant Coadministered With Sumatriptan and of the Safety of Ubrogepant With Triptans. Issue 7 (23rd June 2020)

Authors:: Jakate, Abhijeet; Boinpally, Ramesh; Butler, Matthew; Lu, Kaifeng; McGeeney, Danielle; Periclou, Antonia
Journal:: Headache
Issue:: Volume 60:Issue 7(2020)
Page Start:: 1340
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene‒related peptide‐targeted monoclonal antibody migraine preventives in participants with migraine: A randomized phase 1b drug–drug interaction study. Issue 4 (5th April 2021)

Authors:: Jakate, Abhijeet; Blumenfeld, Andrew M.; Boinpally, Ramesh; Butler, Matthew; Borbridge, Lisa; Contreras‐De Lama, Janette; McGeeney, Danielle; Periclou, Antonia; Lipton, Richard B.
Journal:: Headache
Issue:: Volume 61:Issue 4(2021)
Page Start:: 642
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Single Therapeutic and Supratherapeutic Doses of Ubrogepant Do Not Affect Cardiac Repolarization in Healthy Adults: Results From a Randomized Trial. Issue 4 (14th December 2019)

Authors:: Jakate, Abhijeet; Boinpally, Ramesh; Butler, Matthew; Lu, Kaifeng; McGeeney, Danielle; Periclou, Antonia
Journal:: Clinical pharmacology & therapeutics
Issue:: Volume 107:Issue 4(2020)
Page Start:: 1014
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗